Press "Enter" to skip to content

US District Court denies Amgen Inc’s request for preliminary injunction against Cipla

Cipla’s cinacalcet hydrochloride tablets in the strengths of 30mg, 60mg and 90mg are generic versions of Sensipar, a branded drug marketed by Amgen Inc.

Original source: https://health.economictimes.indiatimes.com/news/pharma/us-district-court-denies-amgen-incs-request-for-preliminary-injunction-against-cipla/69161352?utm_source=RSS&utm_medium=ETRSS

Also Read:   Higher education doesn't protect equally against secondhand smoke